Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC

Clinical trial NCT05652920 · RECRUITING

Trial details

NCT number: NCT05652920
Sponsor: OriCell Therapeutics Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2022-12-15
Primary completion: 2026-12-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.